What is OneSkin?
OneSkin operates at the intersection of biotechnology and consumer wellness, focusing on the development of topical supplements that address skin aging at the molecular level. Founded by a team of four female scientists, the company spent five years evaluating over 900 peptides to isolate OS-01, a proprietary ingredient engineered to reverse the biological age of skin cells. Unlike conventional skincare brands that focus primarily on surface-level aesthetics, OneSkin targets the underlying cellular dysfunction that contributes to skin degradation. This research-first methodology has allowed the company to build a robust portfolio of skin health essentials designed to optimize cellular functionality and extend the lifespan of the skin barrier, effectively bridging the gap between clinical dermatology and daily consumer care.
How much funding has OneSkin raised?
OneSkin has raised a total of $20M across 1 funding round:
Other Financing Round
$20M
Other Financing Round (2025): $20M with participation from Prelude Growth Partners
Key Investors in OneSkin
Prelude Growth Partners
Prelude Growth Partners is a venture capital firm specializing in high-growth consumer brands, with a particular focus on category-disrupting companies in the clean beauty, clinical skincare, and wellness sectors.
What's next for OneSkin?
With this latest round of financing, OneSkin is well-positioned to scale its operations and expand the reach of its OS-01 technology. The company's strategic roadmap likely involves deepening its clinical research pipeline to explore further applications of its peptide technology while simultaneously scaling its distribution channels to meet the rising demand for science-backed longevity products. As the brand transitions into a more mature phase of its lifecycle, the focus will shift toward maintaining its competitive advantage in the biotech skincare space, potentially exploring new product categories that leverage its core molecular expertise to address broader aspects of human health and aging.
See full OneSkin company page
